A quarter of total vaccine exports happened since Nov: Govt data

India will soon cross 100 million vaccine exports. Bangladesh and Indonesia purchased the maximum number of doses since November, shows MEA data

Covishield
(Photo: PTI)
Ishaan Gera New Delhi
1 min read Last Updated : Dec 21 2021 | 12:54 AM IST
India was one of the few countries to have exported doses to over 88 countries back in April, when the world over countries were hoarding vaccines. While India stopped vaccine exports as the second wave of Covid-19 gripped the country, it restarted vaccine exports in November.

In fact, over a quarter of total doses exported by India have come since November. While the country had exported 70.4 million doses till November, data from the ministry of external affairs shows that it has since then exported 24.2 million doses.


While two-thirds of the supply has gone towards commercial considerations, one-third has been supplied to the COVAX alliance.

Nepal and Bangladesh have been the biggest beneficiaries, having cornered 5.8 million of the 7.2 million doses given by India to COVAX since November.

Bangladesh, data indicates, along with Indonesia, also received over 80 per cent of the doses given for commercial considerations.


While India had given 11.7 million doses as grant till October this year, Iran has been the only country to receive a grant of 1 million doses in October.

Meanwhile, first dose vaccinations in India have slowed down. Although the country was expected to vaccinate most of the adult population with one dose by the end of December, it has only been able to cover 826 million people, against a target of 940 million. The fully vaccinated population stands at 548 million.

World over only 56 per cent of the people have been vaccinated once. In Africa, where vaccine availability is still an issue, only 13 per cent of the people have been partially vaccinated.

As the world grapples with a new coronavirus variant, there is a need to increase the vaccination in under-served regions.

Data from Our World in Data shows that while 70 per cent of people were fully vaccinated in upper middle income and high-income countries, lower middle-income countries had only fully vaccinated only 32 per cent of their total population. The coverage in low-income countries was a paltry 3.7 per cent.


One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

Next Story